In Vitro Determination of the Optimal Particle Size for Nebulized Aerosol Delivery to Infants
- 1 June 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 18 (2) , 225-235
Abstract
We investigated the in vitro influence of breathing patterns on lung dose (LD) and particle size distribution in an infant upper airway cast model in order to determine the optimal particle size for nebulized aerosol delivery to infants. Budesol (nebulizer solution of budesonide) delivery from a perforated vibrating membrane nebulizer (eFlow® Baby functional prototype) through an upper airway cast of a nine month old infant (SAINT-model) was measured at a fixed respiratory rate (RR) of 30 breaths per minute (bpm) and a tidal volume (Vt) of 50, 100, and 200 mL, respectively, and at a fixed Vt of 100 mL and a RR of 30, 60, and 78 bpm, respectively. LD expressed as a percentage of the nominal dose (ND; range, 5.8–30.3%) decreased with increasing Vt (p < 0.001) and with increasing RR (p < 0.001). Median mass aerodynamic diameter (MMAD) after passage (range, 2.4–3.4 μm) through the upper airway cast showed a negative correlation with increasing Vt (p < 0.001) and with increasing RR (p = 0.015). Particles available as LD for all simulated breathing pattern showed a particle size distribution with a MMAD of 2.4 μm and a geometric standard deviation (GSD) of 1.56. From our in vitro study, we conclude that the optimal particle size for nebulized aerosols for inhalation therapy for infants should have a MMAD of <2.4 μm.Keywords
This publication has 29 references indexed in Scilit:
- Aerosol Therapy and the Fighting Toddler: Is Administration During Sleep an Alternative?Journal of Aerosol Medicine, 2003
- The output of budesonide from spacer devices assessed under simulated breathing conditionsJournal of Allergy and Clinical Immunology, 1999
- Metered Dose Inhaler Add-On Devices: Is the Inhaled Mass of Drug Dependent on the Size of the Infant?Journal of Aerosol Medicine, 1999
- Respiratory pathophysiologic responsesJournal of Allergy and Clinical Immunology, 1998
- Lung deposition from the Turbuhaler in children with cystic fibrosisEuropean Respiratory Journal, 1997
- Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstructionThe Journal of Pediatrics, 1996
- Effect of Age Related Breathing Parameters on the Performance of a New Nebulizer System: An In-Vitro StudyJournal of Aerosol Medicine, 1995
- Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizerJournal of Paediatrics and Child Health, 1994
- Reference ranges for respiratory rate measured by thermistry (12-84 months).Archives of Disease in Childhood, 1993
- Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation.Thorax, 1993